Memorandum of Understanding Between the Food and Drug Administration and the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology
---
identifier: "/us/fr/04-17513"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Memorandum of Understanding Between the Food and Drug Administration and the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology"
title_number: 0
title_name: "Federal Register"
section_number: "04-17513"
section_name: "Memorandum of Understanding Between the Food and Drug Administration and the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology"
positive_law: false
currency: "2004-08-02"
last_updated: "2004-08-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "04-17513"
document_type: "notice"
publication_date: "2004-08-02"
agencies:
- "Health and Human Services Department"
- "Food and Drug Administration"
fr_citation: "69 FR 46157"
fr_volume: 69
docket_ids:
- "FDA 225-04-4004"
effective_date: "2004-03-29"
fr_action: "Notice."
---
# Memorandum of Understanding Between the Food and Drug Administration and the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice.
**SUMMARY:**
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, to establish the framework for a collaborative partnership on mutually agreed activities in the areas of scientific research and education.
**DATES:**
The agreement became effective March 29, 2004.
**FOR FURTHER INFORMATION CONTACT:**
Mary I. Poos, Office of External Relations (HF-10), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-2825.
**SUPPLEMENTARY INFORMATION:**
In accordance with 21 CFR 20.108(c), which states that all written agreements and MOU's between FDA and others shall be published in the *Federal Register* , the agency is publishing notice of this MOU.
Dated: July 21, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.